BlueStem Wealth Partners’s Boston Scientific BSX Stock Holding History

BlueStem Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$753K	Buy	17,646 +90	+0.5%	+$4.89K	0.08%	69
2026 Q1	$1.1M	Buy	17,556 +49	+0.3%	+$3.92K	0.12%	60
2025 Q4	$1.67M	Sell	17,507 -273	-2%	-$26.8K	0.18%	49
2025 Q3	$1.74M	Sell	17,780 -212	-1%	-$22K	0.2%	42
2025 Q2	$1.93M	Buy	17,992 +1,704	+10%	+$172K	0.24%	38
2025 Q1	$1.64M	Sell	16,288 -356	-2%	-$35.8K	0.22%	37
2024 Q4	$1.49M	Buy	+16,644	New	+$1.47M	0.2%	42

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlueStem Wealth Partners's BSX Position: Q2 2026 in Review

BlueStem Wealth Partners increased its Boston Scientific (BSX) stake by 0.51% in Q2 2026, buying an estimated $4.89K and bringing the position to 17,646 shares worth $753K. The position accounts for 0.08% of the portfolio, ranked #69.

BlueStem Wealth Partners first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.93M in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

BlueStem Wealth Partners held 17,646 shares of Boston Scientific worth $753K as of Q2 2026.
BlueStem Wealth Partners bought 90 Boston Scientific shares in Q2 2026, an estimated $4.89K.
Boston Scientific made up 0.08% of BlueStem Wealth Partners's portfolio in Q2 2026, its #69 holding.
BlueStem Wealth Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
BlueStem Wealth Partners's Boston Scientific position peaked at $1.93M in Q2 2025.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on BlueStem Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.